CME Group (NASDAQ:CME) Price Target Raised to $287.00 at Keefe, Bruyette & Woods

CME Group (NASDAQ:CME) had its price objective increased by Keefe, Bruyette & Woods from $283.00 to $287.00 in a research report sent to investors on Monday,MarketScreener reports. Keefe, Bruyette & Woods currently has a market perform rating on the financial services provider’s stock.

CME has been the subject of several other reports. Barclays cut their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 8th. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. UBS Group cut their price objective on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research report on Monday, September 8th. Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Finally, Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $283.43.

CME Group Trading Down 0.1%

Shares of NASDAQ:CME opened at $271.28 on Monday. CME Group has a 52-week low of $213.94 and a 52-week high of $290.79. The company has a market capitalization of $97.76 billion, a P/E ratio of 26.26, a price-to-earnings-growth ratio of 5.72 and a beta of 0.41. The company has a 50-day simple moving average of $268.57 and a 200 day simple moving average of $271.35. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the business posted $2.56 EPS. CME Group’s revenue was up 10.4% on a year-over-year basis. Sell-side analysts forecast that CME Group will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Insider Buying and Selling at CME Group

In other news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 over the last ninety days. Company insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Webster Bank N. A. increased its stake in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the last quarter. Highline Wealth Partners LLC increased its stake in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Wayfinding Financial LLC bought a new position in CME Group in the first quarter valued at approximately $25,000. Cornerstone Planning Group LLC increased its stake in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Finally, Sagard Holdings Management Inc. bought a new position in CME Group in the second quarter valued at approximately $30,000. 87.75% of the stock is owned by institutional investors.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.